Microscopic Colitis
Microscopic Colitis is a relatively new type of colitis,
recognized since the 1980’s as a form of microscopic
inflammation, which causes chronic diarrhea. All stool
studies, labs and x-rays are usually normal. Even the
Colonoscopy appears normal, and only if biopsies are taken and
examined under the microscope can the diagnosis be made.
There are 2 types that we find: (1) Lymphatic colitis (equal in
men and women) and (2) collagenous colitis (5:1, female: male
ratio). Sometimes a single individual has both types.
Patients usually have non-bloody diarrhea with stools ranging
from less than or equal to 3/day (33%), to 4-9/day (52%) and
more than 10/day (15%). In our study 47% of cases began
suddenly and 53% insidiously. 66% of patients had only one
episode of colitis, whereas 34% had either recurrent bouts or
chronic symptoms. This is in contrast to other studies
that showed few single episodes, and mostly chronic intermittent
problems. 10% of our patients had concomitant celiac
disease.
Treatments can include antibiotics such as Azulfidine & Flagyl,
Lomotil/Immodium, and steroids, which were the most effective
(Prednisone, Entocort).
As opposed to other studies we found only about 22% had
abdominal pain or weight loss.
In summary, microscopic colitis is primarily a disease of middle
aged women, can begin suddenly or insidiously, with the majority
improving within 2 months. Some will have chronic or
recurrent diarrhea and require ongoing therapy, the most
successful being low dose Prednisone. The overall number
of cases is still small and it appears to still lag far behind
the frequency of ulcerative colitis.
In our study, we had a total of 39 patients with microscopic
colitis over the past 10 years. 78% female and 22% male.
There were equal numbers of males and females with lymphocytic
colitis, but 5 times as many females had collagenous colitis.
The clinical presentations were sudden onset of diarrhea in 47%
and insidious diarrhea in 53%. 66% were cured with their
first episode, but 34% had either recurrent bouts or chronic
continuous symptoms.
Prednisone was the treatment of choice, effective in almost
every case.
Of note, almost 10% of our patients had celiac disease.
The complete abstract will be made available once it is published.
